Based on the Defence Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Defence Therapeutics Inc is not available over the next 12 months. Defence Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Defence Therapeutics Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Defence Therapeutics Inc’s stock price was CAD 0.55. Defence Therapeutics Inc’s stock price has changed by +0.00% over the past week, -19.12% over the past month and -79.63% over the last year.
No recent analyst target price found for Defence Therapeutics Inc
No recent average analyst rating found for Defence Therapeutics Inc
Company Overview Defence Therapeutics Inc
Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Vancouver, Canada. Address: 1680 ? 200 Burrard Street, Vancouver, BC, Canada, V6C 3L6 Read Less
Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development ...Read More
N/A
N/A
0
N/A
CAD
Canada
Adjusted Closing Price for Defence Therapeutics Inc (DTC:CA)
Loading...
Unadjusted Closing Price for Defence Therapeutics Inc (DTC:CA)
Loading...
Share Trading Volume for Defence Therapeutics Inc Shares
Loading...
Compare Performance of Defence Therapeutics Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for DTC:CA
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Defence Therapeutics Inc (Sector: Biotechnology )
Frequently Asked Questions About Defence Therapeutics Inc (DTC:CA) Stock
Stock Target Advisor's fundamental analysis for Defence Therapeutics Inc's stock is Bearish.
Unfortunately we do not have enough data on DTC:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on DTC:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on DTC:CA's stock to indicate if its overvalued.
The last closing price of DTC:CA's stock was CAD 0.55.
The most recent market capitalization for DTC:CA is CAD 0.02B.
Unfortunately we do not have enough analyst data on DTC:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Defence Therapeutics Inc's stock.
As per our most recent records Defence Therapeutics Inc has 0 Employees.
Sorry we do not have any infomation available on Defence Therapeutics Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Defence Therapeutics Inc (DTC:CA) Stock
Stock Target Advisor's fundamental analysis for Defence Therapeutics Inc's stock is Bearish.
Unfortunately we do not have enough data on DTC:CA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on DTC:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on DTC:CA's stock to indicate if its overvalued.
The last closing price of DTC:CA's stock was CAD 0.55.
The most recent market capitalization for DTC:CA is CAD 0.02B.
Unfortunately we do not have enough analyst data on DTC:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Defence Therapeutics Inc's stock.
As per our most recent records Defence Therapeutics Inc has 0 Employees.
Sorry we do not have any infomation available on Defence Therapeutics Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DTC:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
